Antiviral, Anti-Inflammatory, and Metabolic Health

How self-heal's rosmarinic acid, ursolic acid, and polysaccharides fight viruses, calm inflammation, and support blood sugar and thyroid health

Prunella vulgaris — commonly called self-heal or heal-all — is a low-growing perennial herb in the mint family that grows wild across Europe, Asia, and North America. Its small purple flower spikes have been used in traditional Chinese, European, and Native American medicine for thousands of years, primarily for sore throats, wounds, and fever [5]. What makes it stand out today is a well-documented combination of antiviral activity against herpes simplex viruses [3], anti-inflammatory action through COX-2 inhibition [1], blood sugar lowering effects in animal models [2], and emerging evidence for thyroid nodule support in clinical trials [4]. It is edible — the young leaves can be added to salads or teas — which makes it one of the few medicinal herbs that is also a common garden plant and forageable food.

How Self-Heal Works

Prunella vulgaris packs several distinct classes of bioactive compounds that work through different mechanisms.

Rosmarinic acid is the dominant polyphenol and the most studied active compound. It is a potent inhibitor of cyclooxygenase-2 (COX-2), the enzyme responsible for producing prostaglandin E2 — a key driver of inflammation and pain. It also inhibits inducible nitric oxide synthase (iNOS), reducing inflammatory nitric oxide production [1]. These are the same pathways targeted by NSAIDs like ibuprofen, but rosmarinic acid's dual COX-2/iNOS inhibition gives it a broader anti-inflammatory profile than drugs that target COX alone. Rosmarinic acid is also found in rosemary, lemon balm, and basil, but self-heal contains particularly high concentrations.

Ursolic acid is a triterpene that adds anti-tumor and metabolic properties. It inhibits certain signaling pathways involved in cell proliferation and is one of the reasons Prunella vulgaris has attracted research interest in thyroid health [5].

Polysaccharides extracted from the plant's flower spikes (spica) are responsible for the most striking antiviral findings. A specific polysaccharide fraction (PVE30) blocks herpes simplex virus attachment to host cells by competing with heparan sulfate — the cell surface receptor HSV uses to enter cells — for binding to viral glycoproteins B and gC [3]. This attachment-blocking mechanism is particularly efficient, with effective concentrations lower at the attachment stage than after infection has already begun.

Anti-Inflammatory Applications

Ethanol extracts of Prunella vulgaris significantly reduce LPS-stimulated prostaglandin E2 and nitric oxide production in macrophages at 30 μg/mL — a concentration low enough to be pharmacologically relevant [1]. The effect is dose-dependent. Notably, rosmarinic acid alone does not fully explain the extract's potency, which indicates other compounds (including ursolic acid and oleanolic acid) contribute synergistically to the anti-inflammatory activity. This synergy between compounds is a recurring theme in whole-plant herb research and one reason whole extracts often outperform isolated constituents.

For practical use, self-heal tea or tincture is used in traditional medicine for sore throats, mouth ulcers, and mild inflammatory conditions. The herb is approved for oral use in Chinese pharmacopoeia, with rosmarinic acid serving as the standardization marker since 2010 [5].

Antiviral Use

The polysaccharide fraction from Prunella vulgaris flower spikes shows potent activity against both HSV-1 and HSV-2 in cell culture. The most efficient window is early — at the virus-cell attachment stage — where effective concentrations are 7–8 times lower than at the post-infection stage [3]. This suggests that topical preparations could be most useful as a prophylactic or at the very first sign of a cold sore outbreak, before the virus has entered cells and established replication.

Earlier in vitro work documented anti-HIV activity from aqueous extracts, though this is far from clinical evidence of benefit in humans.

Blood Sugar and Metabolic Support

Aqueous-ethanol extracts of Prunella vulgaris administered to streptozotocin-diabetic mice significantly lowered fasting blood glucose at doses of 100–400 mg/kg [2]. The mechanisms appear to involve multiple pathways: rosmarinic acid inhibits alpha-glucosidase (slowing carbohydrate digestion), ursolic acid improves insulin sensitivity, and aldose reductase inhibition (which reduces conversion of glucose to sorbitol) may protect against diabetic complications like neuropathy and retinopathy [5]. These are all distinct, complementary mechanisms rather than a single mode of action.

No human clinical trials have tested Prunella vulgaris for blood sugar control, so the evidence remains preclinical.

Thyroid Support

In traditional Chinese medicine, the spica (dried flower spike) is the most prized preparation and has a centuries-long history of use for thyroid-related swelling. Modern clinical trials — mostly conducted in China and using standardized preparations — have investigated Prunella vulgaris combined with levothyroxine for thyroid nodules. A 2021 meta-analysis of 13 RCTs found meaningful improvements in nodule size and clinical response rates compared to levothyroxine alone [4].

Dosage and Forms

Tea: 3–5 g of dried aerial parts or spica steeped in hot water for 10–15 minutes, taken two to three times daily. Traditional preparation for throat and mouth conditions.
Tincture: 1:5 in 25% alcohol; typical dose 2–4 mL three times daily.
Standardized extract (spica): Follow label guidance; Chinese pharmacopoeia standardizes on rosmarinic acid content.
Topical: Aqueous extracts can be applied directly to cold sores or mouth ulcers; the polysaccharides are water-soluble and most effective at attachment stage.

Self-heal is generally well-tolerated with a very low incidence of adverse effects across traditional use and modern trials. It is commonly foraged as an edible plant — the leaves and flowers are mild-tasting and can be added to salads or soups.

See our lemon balm page for more on another high-rosmarinic-acid mint-family herb, and our cold sores page for context on natural antiviral approaches.

Evidence Review

Anti-Inflammatory Mechanism via Rosmarinic Acid (Huang et al., 2009)

This study published in the Journal of Agricultural and Food Chemistry is the foundational work characterizing Prunella vulgaris's anti-inflammatory mechanism [1]. Researchers tested water and ethanol extracts from four P. vulgaris accessions on LPS-stimulated RAW 264.7 mouse macrophages — the standard cell model for innate immune inflammation. Ethanol extracts at 30 μg/mL significantly inhibited prostaglandin E2 (PGE2) and nitric oxide (NO) production without cytotoxicity. Western blotting confirmed that COX-2 and iNOS protein expression were both reduced by whole extracts, while purified rosmarinic acid suppressed COX-2 but not iNOS — indicating other compounds account for the iNOS inhibition.

The rosmarinic acid content in the four accessions varied substantially (range not specified in public summaries), which explained much but not all of the variation in anti-inflammatory potency between accessions. This variation matters for consumers: standardized extracts anchored to rosmarinic acid content are more reliable than wild-foraged or unstandardized products.

Key limitation: in vitro macrophage models do not directly predict clinical efficacy. The relevant concentrations (30 μg/mL) are achievable in tissue via oral dosing, but bioavailability studies for whole P. vulgaris extracts are limited.

Blood Sugar Lowering in Diabetic Animal Models (Zheng et al., 2007)

This Asia Pacific Journal of Clinical Nutrition study induced diabetes in ICR mice using streptozotocin (STZ), which destroys pancreatic beta cells and produces insulin-deficient hyperglycemia [2]. Aqueous-ethanol extract of P. vulgaris at 100–400 mg/kg significantly reduced fasting blood glucose compared to untreated diabetic controls. Acute glucose tolerance testing showed that the extract at 100 mg/kg suppressed the glucose spike by 30 minutes post-load. The extract also improved exogenous insulin sensitivity, suggesting peripheral effects beyond insulin secretion.

The study does not isolate the active compound responsible, and dosing in mg/kg cannot be directly converted to human equivalents without pharmacokinetic data. No human clinical trials for blood sugar have followed.

Evidence level: preclinical (rodent). Suggestive but not confirmatory.

Polysaccharide Antiviral Activity Against HSV (Zhong et al., 2024)

This 2024 study in Chinese Medicine is the most mechanistically detailed investigation of Prunella vulgaris's antiviral properties [3]. The polysaccharide fraction PVE30 (extracted by hot water with 30% ethanol precipitation) was tested against HSV-1 and HSV-2 using plaque reduction assays, immunofluorescence, heparin bead pull-down assays, real-time PCR, and Western blotting.

Key findings:

PVE30 showed EC50 values of 33.36 ± 0.77 μg/mL (HSV-1) and 26.61 ± 0.86 μg/mL (HSV-2) at post-infection stage
At the attachment stage, EC50 values dropped to 4.53 ± 0.21 μg/mL (HSV-1) and 4.61 ± 0.40 μg/mL (HSV-2) — roughly 7-fold more potent
The polysaccharide competed with heparan sulfate for binding to viral glycoproteins B and gC, physically blocking viral attachment
PVE30 downregulated immediate-early (IE) viral genes, suppressing downstream early (E) and late (L) gene products and reducing progeny virus yield
The compound inhibited TLR2 and TLR3 signaling, reducing NF-κB activation and downstream IL-6 and TNF-α
HSV-1-induced necroptosis was blocked by reduced MLKL phosphorylation

This multi-mechanism profile — physical blocking of attachment, gene expression suppression, immune signaling modulation, and cell death prevention — is unusually comprehensive for a single herbal extract fraction. The attachment-blocking mechanism is distinct from the nucleoside analogue antivirals (acyclovir, valacyclovir) which target viral DNA polymerase, suggesting potential complementary use.

Key limitation: all data are in vitro (Vero cells). Topical formulation and systemic bioavailability of polysaccharides are challenges not yet addressed in human trials.

Thyroid Nodule Meta-Analysis (Han et al., 2021)

This meta-analysis published in Medicine searched eight databases through April 2021 and identified 13 eligible RCTs involving 1,468 patients with thyroid nodules [4]. All trials used Prunella vulgaris preparations (spica decoctions or granules) combined with levothyroxine sodium versus levothyroxine alone.

Key pooled results:

Clinical response rate: RR 1.22 (95% CI 1.11–1.33), meaning PV combined with levothyroxine increased the probability of clinical response by 22% relative to levothyroxine alone
Nodule diameter: Mean difference −0.43 cm (95% CI −0.63 to −0.22 cm), a statistically significant reduction in nodule size
Adverse reactions: Pooled data showed the combination did not increase adverse events compared to levothyroxine alone

Limitations: All 13 trials were conducted in China with Chinese preparations, limiting generalizability. Methodological quality varied; risk-of-bias assessment found moderate concern in several trials. The levothyroxine dosing protocols differed across studies. Publication bias is likely given the origin of the trials. Nevertheless, the consistency of effect across 13 independent studies and the large total sample size give the meta-analysis reasonable weight.

This represents the strongest clinical evidence base for Prunella vulgaris and the only domain with Level 2 human trial evidence. The traditional use of Prunella vulgaris spica for thyroid-related swelling (recorded in Chinese medicine texts for over 2,000 years) appears to have a biologically plausible and clinically measurable basis.

Comprehensive Phytochemical and Pharmacological Review (Pan et al., 2022)

This 2022 Frontiers in Pharmacology review by Pan, Wang, and Chen synthesizes the entire evidence base for Prunella vulgaris — botany, ethnopharmacology, phytochemistry, analytical methods, and pharmacological effects [5]. It identifies over 70 compounds including rosmarinic acid, ursolic acid, oleanolic acid, caffeic acid, hyperoside, and complex polysaccharides.

The review notes rosmarinic acid's dual function as an anti-inflammatory agent and alpha-glucosidase inhibitor, and connects ursolic acid and oleanolic acid to antitumor activity via STAT3 pathway inhibition in hepatocellular carcinoma cell lines. The thyroid research thread is discussed extensively, noting that anti-inflammatory and antiproliferative mechanisms both likely contribute to observed clinical effects on thyroid nodules.

Key gaps identified: few pharmacokinetic studies exist for Prunella vulgaris preparations, dosing is not standardized across preparations, and the number of rigorous human trials outside the thyroid nodule domain is very limited.

Evidence Strength Summary

Application	Evidence Level	Key Finding
Thyroid nodule reduction	Moderate (13 RCTs, meta-analysis)	22% better clinical response + 0.43 cm nodule reduction vs. levothyroxine alone
Anti-inflammatory	Moderate preclinical	COX-2 and iNOS inhibition by rosmarinic acid; in vitro and rodent data
Antiviral (HSV)	In vitro only	7x more potent at attachment stage; distinct mechanism from acyclovir
Blood sugar	Preclinical (rodent)	Fasting glucose reduced in diabetic mice; multiple enzyme targets
Antifungal, wound healing	Traditional use/in vitro	Limited mechanistic data, no clinical trials

Overall confidence: moderate for thyroid nodule applications, low-moderate for anti-inflammatory use, in vitro only for antiviral and antidiabetic claims in humans. Prunella vulgaris is a well-characterized medicinal plant with 2,000+ years of traditional use, a rich phytochemistry, strong mechanistic evidence in cell and animal models, and an emerging clinical evidence base for thyroid applications. It is most credibly used as a complementary agent alongside conventional treatment rather than as a primary therapeutic.

References

Rosmarinic acid in Prunella vulgaris ethanol extract inhibits lipopolysaccharide-induced prostaglandin E2 and nitric oxide in RAW 264.7 mouse macrophagesHuang N, Hauck C, Yum MY, Rizshsky L, Widrlechner MP, McCoy JA, Murphy PA, Dixon PM, Nikolau BJ, Birt DF. Journal of Agricultural and Food Chemistry, 2009. PubMed 19919113 →
Antihyperglycemic activity of Prunella vulgaris L. in streptozotocin-induced diabetic miceZheng J, He J, Ji B, Li Y, Zhang X. Asia Pacific Journal of Clinical Nutrition, 2007. PubMed 17392144 →
Prunella vulgaris polysaccharide inhibits herpes simplex virus infection by blocking TLR-mediated NF-κB activationZhong X, Zhang Y, Yuan M, Xu L, Luo X, Wu R, Xi Z, Li Y, Xu H. Chinese Medicine, 2024. PubMed 38185640 →
Safety and efficacy of Prunella vulgaris preparation in adjuvant treatment of thyroid nodules: A meta-analysisHan Q, Xu N, Chen B, Wu W, Sheng L. Medicine, 2021. PubMed 34731129 →
Prunella vulgaris L. – A Review of its Ethnopharmacology, Phytochemistry, Quality Control and Pharmacological EffectsPan J, Wang H, Chen Y. Frontiers in Pharmacology, 2022. PubMed 35814234 →